
WHO Releases Guideline On Bedaquiline, Delamanid Use For Drug-resistant TB In Children
By Olasunkanmi Jumoke The World Health Organisation (WHO) has published information notes regarding the dosage and administration of bedaquiline and delamanid in children and adolescents with drug-resistant tuberculosis (DR-TB). In a statement issued on Wednesday, the organisation underlined that these medications are considered innovative and have shown promising results in treating DR-TB, a condition that…